Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
52
days
From Fragment Hit to Clinical Candidate: Discovery of Dual H1R/H4R Ligands with Superior Efficacy in Allergic Conjunctivitis
Authors
Peter Weber; Rogier Smits; Herman D. Lim; Mounir Andaloussi; Jac Wijkmans; Bas de Boer; Thuy Duong Tran; Barbara Zarzycka; Mabel E. Dekker; Tiffany van der Meer; Rick Riemens; Niels Hauwert; Gabor Wagner; Henry F. Vischer; Matthew J. Chapin; Paul Gomes; Andy Whitlock; Maikel Wijtmans; Rob Leurs; Iwan J. P. de EschShow moreShow less
Affiliations
1. Division of Medicinal Chemistry, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Department of Chemistry & Pharmaceutical Sciences, 1190Vrije Universiteit Amsterdam, De Boelelaan 1083, Amsterdam 1081 HV, The Netherlands; 2. Griffin Discoveries BV, De Boelelaan 1083, KA-323, Amsterdam 1081 HV, The Netherlands; 3. Ora, LLC, 138 Haverhill Street, Suite 102, Andover, Massachusetts 01810, United StatesShow moreShow less
146
days
A Subcellular Keap1-Nrf2 Disruption Strategy for Atopic Dermatitis Therapy
Authors
Zixi Zhang; Jia Wu; Jingqi Liu; Daniel Shiu-Hin Chan; Chun-Yuen Wong; Jing Wang; Chung-Hang Leung; Wanhe WangShow moreShow less
Affiliations
1. School of Life Science and Technology, 26487Northwestern Polytechnical University, 1 Dongxiang Road, Xi’an, Shaanxi 710072, China; 2. Research & Development Institute of Northwestern Polytechnical University in Shenzhen, 45 South Gaoxin Road, Shenzhen, Guangdong 518057, China; 3. State Key Laboratory of Mechanism and Quality of Chinese Medicine, 59193University of Macau, Taipa, Macao SAR 999078, China; 4. Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao SAR 999078, China; 5. Department of Chemistry, 2152City University of Hong Kong, Kowloon, Hong Kong 999077, China; 6. College of Chemistry and Materials Science, State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510632, ChinaShow moreShow less
238
days
Development of Covalent Inhibitors of Chikungunya Virus nsP2 Cysteine Protease Enabled by Direct-to-Biology Synthesis and Screening
Authors
Zhengjun Cai; Kan Li; Sainetra Sridhar; Haozhou Tan; Hiwot Demssie; Gaungjin Fan; Wenyi Zhang; Bobby Brooke Herrera; Jun WangShow moreShow less
Affiliations
1. Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States; 2. Rutgers Global Health Institute, New Brunswick, New Jersey 08901, United States; 3. Department of Medicine, Division of Allergy, Immunology, and Infectious Diseases, and Child Health Institute of New Jersey, 12287Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, United StatesShow moreShow less
116
days
Discovery of Highly Efficacious CRBN-Based KRAS Degraders Targeting Cancers with KRAS G12D and G12V Mutations
Authors
Changwei Wang; Prithwish Ghosh; Shicheng Jin; Longchuan Bai; Angelo Aguilar; Donna McEachern; Mi Wang; Qiuxia Li; Bo Wen; Duxin Sun; Shaomeng WangShow moreShow less
Affiliations
1. Department of Internal Medicine, 1259University of Michigan, Ann Arbor, Michigan 48109, United States; 2. Department of Pharmaceutical Sciences, 1259University of Michigan, Ann Arbor, Michigan 48109, United States; 3. Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States; 4. Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States; 5. Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109, United StatesShow moreShow less
51
days
The Discovery of GSK3227634: A Potent Inhaled Inhibitor of the KEAP1/NRF2 Protein–Protein Interaction for the Treatment of Chronic Obstructive Pulmonary Disease
Authors
James F. Callahan; Thomas G. Davies; Marcus Bantscheff; Sabrina Bedard; Jeffrey Boehm; Catherine Booth-Genthe; Nestor Concha; Roy Copley; Alicia Davis; Roderick Davis; Dirk Eberhard; Joseph Foley; Pearl Flamberg; Nicole C. Goodwin; Tom D. Heightman; Steven R. Katchur; Jeffrey K. Kerns; Casey Kmett; Charles J. Kotzer; Philip Landis; Tindy Li; Derrick Meinhold; Marcel Mülbaier; Hong Nie; Ruth R. Osborn; Torren M. Peakman; Brian Peck; Patricia L. Podolin; Thomas Sweitzer; Hongxing Yan; Paris Ward; Thilo Werner; Lawrence A. Wolfe III; Alison J.-A. Woolford; Zining Wu; Yolanda Sanchez; William L. RumseyShow moreShow less
Affiliations
1. 33139GSK, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States; 2. 2145Astex Pharmaceuticals, 436 Cambridge Science Park, Cambridge CB4 0QA, U.K.; 3. 580818Cellzome GmbH, a GSK Company, Heidelberg 69117, Germany; 4. GSK, Gunnels Wood Road, Stevenage SG1 2NY, Hertfordshire, U.K.Show moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days